Fox Run Management L.L.C. Has $459,000 Stake in Koninklijke Philips (NYSE:PHG)

Fox Run Management L.L.C. lifted its stake in Koninklijke Philips (NYSE:PHG) by 190.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,109 shares of the technology company’s stock after purchasing an additional 11,872 shares during the quarter. Fox Run Management L.L.C.’s holdings in Koninklijke Philips were worth $459,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Wilmington Savings Fund Society FSB purchased a new stake in Koninklijke Philips in the 3rd quarter worth approximately $54,000. Farther Finance Advisors LLC increased its stake in shares of Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after acquiring an additional 582 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Koninklijke Philips during the fourth quarter worth $55,000. Millstone Evans Group LLC acquired a new stake in Koninklijke Philips during the fourth quarter valued at $60,000. Finally, Allworth Financial LP grew its stake in Koninklijke Philips by 24.9% in the fourth quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock valued at $105,000 after purchasing an additional 797 shares in the last quarter. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Koninklijke Philips Stock Up 0.1 %

Shares of PHG stock opened at $25.47 on Wednesday. The stock’s 50 day simple moving average is $26.74 and its 200 day simple moving average is $27.64. Koninklijke Philips has a twelve month low of $19.10 and a twelve month high of $32.91. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23. The company has a market capitalization of $23.94 billion, a price-to-earnings ratio of -30.32, a PEG ratio of 0.82 and a beta of 0.78.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The firm had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. As a group, research analysts predict that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio (DPR) is -89.29%.

Analyst Ratings Changes

PHG has been the subject of a number of recent research reports. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 18th. BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. UBS Group raised shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday, February 20th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.